Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
No open-market purchases or sales by Tiziana Life Sciences Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q3 2026, worth $4.43M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 20, 2026
- $74.8M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +4 vs. previous quarter
- 35
- 13F valueReported value at the end of Q3 2026
- $4.43M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2024
- –
- No comparable prior period
- Net income, FY2024
- -$11.9M
- No comparable prior period
- Free cash flow, FY2024
- -$1.54M
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.92M
- Shares sold short
- Change
- +131.4K
- +4.7% vs. previous
- Days to cover
- 6.98
- At average daily volume
Superinvestors holding TLSA, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding TLSA at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Tiziana Life Sciences Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)4:16 PM ET | Jul 21 | 17 days | Cerrone Gabriele MDirector, 10% Owner | PPurchase | +42.4K | $0.99 | +$41.9K | +0.1%44.8M after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jun 12 | 56 days | Cerrone Gabriele MDirector, 10% Owner | PPurchase | +15.0K | $1.11 | +$16.6K | 0.0%44.8M after | Amended |
| Aug 6, 2026 (view filing)9:30 AM ET | Aug 4-5 | 2 days | Elrifi IvorChief Executive Officer | PPurchase | +321.4K | $0.9922 | +$318.9K | +7.2%4.79M after | 2 lots |
| Aug 5, 2026 (view filing)4:30 PM ET | Aug 3 | 2 days | Elrifi IvorChief Executive Officer | PPurchase | +667.0K | $1.00 | +$667.0K | +17.5%4.47M after |
Top 10 13F holders, Q3 2026
See all 35 holdersThe largest institutional positions in Tiziana Life Sciences Ltd at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 1,184,845 | $1.32M | 0.00% | +1,184,845 | New |
| Citadel Advisors LLC | 615,965 | $683.7K | 0.00% | +535,743+667.8% | Added |
| Renaissance Technologies LLC | 500,133 | $555.1K | 0.00% | +487,033+3,717.8% | Added |
| Mid-American Wealth Advisory Group, Inc. | 448,667 | $498.0K | 0.17% | +125,427+38.8% | Added |
| Dauntless Investment Group, LLC | 301,001 | $334.1K | 0.61% | −860,999−74.1% | Reduced |
| Goldman Sachs Group Inc | 152,611 | $169.4K | 0.00% | +33,373+28.0% | Added |
| Zhang Financial LLC | 140,350 | $155.8K | 0.00% | +14,400+11.4% | Added |
| Jane Street Group, LLC | 120,816 | $134.1K | 0.00% | +107,022+775.9% | Added |
| Colony Group, LLC | 79,365 | $88.1K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 62,437 | $67.4K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of TLSA
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Tiziana Life Sciences Ltd.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Fonda Laura Natalia Monica | 13G | 5.70%6.81M shares | – | May 4, 20222 filings | Oct 28, 2025 | SEC |